Style | Citing Format |
---|---|
MLA | Hajianfar H, et al.. "Lipid Profiles and Serum Visfatin Concentrations in Patients With Type Ii Diabetes in Comparison With Healthy Controls." International Journal of Preventive Medicine, vol. 3, no. 5, 2012, pp. 326-331. |
APA | Hajianfar H, Bahonar A, Entezari MH, Askari G, Yazdani M (2012). Lipid Profiles and Serum Visfatin Concentrations in Patients With Type Ii Diabetes in Comparison With Healthy Controls. International Journal of Preventive Medicine, 3(5), 326-331. |
Chicago | Hajianfar H, Bahonar A, Entezari MH, Askari G, Yazdani M. "Lipid Profiles and Serum Visfatin Concentrations in Patients With Type Ii Diabetes in Comparison With Healthy Controls." International Journal of Preventive Medicine 3, no. 5 (2012): 326-331. |
Harvard | Hajianfar H et al. (2012) 'Lipid Profiles and Serum Visfatin Concentrations in Patients With Type Ii Diabetes in Comparison With Healthy Controls', International Journal of Preventive Medicine, 3(5), pp. 326-331. |
Vancouver | Hajianfar H, Bahonar A, Entezari MH, Askari G, Yazdani M. Lipid Profiles and Serum Visfatin Concentrations in Patients With Type Ii Diabetes in Comparison With Healthy Controls. International Journal of Preventive Medicine. 2012;3(5):326-331. |
BibTex | @article{ author = {Hajianfar H and Bahonar A and Entezari MH and Askari G and Yazdani M}, title = {Lipid Profiles and Serum Visfatin Concentrations in Patients With Type Ii Diabetes in Comparison With Healthy Controls}, journal = {International Journal of Preventive Medicine}, volume = {3}, number = {5}, pages = {326-331}, year = {2012} } |
RIS | TY - JOUR AU - Hajianfar H AU - Bahonar A AU - Entezari MH AU - Askari G AU - Yazdani M TI - Lipid Profiles and Serum Visfatin Concentrations in Patients With Type Ii Diabetes in Comparison With Healthy Controls JO - International Journal of Preventive Medicine VL - 3 IS - 5 SP - 326 EP - 331 PY - 2012 ER - |